Answers are grounded in this paper and cite their sources.
SMYD2 is one of the five members (SMYD1-5) of the Su(Var)3-9, Enhancer-of-zeste and Trithorax (SET) and Myeloid, Nervy, and DEAF-1 (MYND) domain-containing (SMYD) protein family and is it known to methylate histone and non-histone substrates. By methylating a wide range of targets, SMYD2 acts as an oncogene in most cancer types.
No takes yet. Share an insight, caveat, or question.
Teresa Rubio‐Tomás (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: